Abstract

MARIN, Juan-David et al. Antibodies associated with neuropsychiatrie lupus: Pathophysiological role, prevalence and diagnostic usefulness. Rev.Colomb.Reumatol. [online]. 2019, vol.26, n.2, pp.111-117.  Epub May 20, 2020. ISSN 0121-8123.  https://doi.org/10.1016/j.rcreu.2018.11.002.

Systemic lupus erythematous (SLE) is a systemic autoimmune disease with the potential to involve any organ. The neurological manifestations are one of the main causes of morbidity and mortality related to SLE, and they can be expressed in the central or peripheral nervous system. Given their complexity, their diagnosis and treatment are a challenge for clinicians. Although there are plenty of helpful laboratory tests and diagnostic imaging tools to achieve a good diagnosis, there is no gold standard available yet. Finding biomarkers with adequate sensitivity and specificity are still being studied. A review is presented in this article on the specific antibodies that have been associated with, or that may trigger, the neurological manifestations in SLE, their pathophysiological importance, prevalence, and their association with this clinical presentation of the illness.

Keywords : Systemic lupus erythematosus; Neuropsychiatric lupus; erythematosus; Antibodies; Anti-ribosomal P; Anti-NMDA.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )